Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age18-60
SponsorWake Forest University Health Sciences

About this trial

The objective of this study is to examine photos of CCCA patients taken before and after treatment to compare treatment outcomes between different treatment groups

Eligibility criteria

Qualifiers

African-American women, ages 18-60 years old

with a clinical diagnosis and biopsy-proven CCCA, with Central Scalp Alopecia Scale severity 1 through 4 will be included in this study

These subjects will be seen and treated in Wake Forest Baptist Health Dermatology Outpatient Clinic

Disqualifiers

Patients with other forms of hair loss in addition to CCCA will be excluded

Other patients to be excluded are those with other forms of inflammatory scalp disease (with the exception of mild seborrheic dermatitis)

patients who have had topical treatment for CCCA within the past 4 months (including topical steroids, topical minoxidil, or any other topical hair regrowth medication)

patients who have been on a long-term oral antibiotics for hair loss within the past year

Trial design

Treatments tested in this trial

  • Topical steroid class I-II
  • Triamcinolone Acetonide
  • Doxycyline
  • Minoxidil

Treatment groups

250 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Wake Forest University Health Sciences

Lead sponsor

The Skin of Color Society

Collaborator